LISATA THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 1341000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-03-31) |
| Status | current |
| Entity | LISATA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:30:05.063946+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3c42ec7b-06e0-4e8b-80ff-81a45309ad26
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000320017-23-000028 · Open the official SEC filing →Retrieved: 2026-08-19T07:30:05.063946+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000320017/accounts-payable/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3c42ec7b-06e0-4e8b-80ff-81a45309ad26
History
- no predecessors — first report